Literature DB >> 6197986

A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.

A P Wilson, C H Ford, C E Newman, A Howell.   

Abstract

In this study cell lines have been used to determine the level of correlation between three assays which are in use for in vitro prediction of human tumour chemosensitivity. The methods which were compared included a clonogenic assay, a monolayer assay and a short-term biochemical assay. The results indicated that the monolayer and clonogenic assays were either directly comparable or could be made comparable by reducing the drug exposure time in the monolayer assay. The biochemical assay also gave comparable results for 3 of the 5 drugs tested. It was concluded that although the 3 assays did not produce identical dose-response curves, the assays were equally valid when used for predictive testing because selection of cut-off points which were based on retrospective correlations between in vitro sensitivity data and response data, as established by other authors, compensated for differences in sensitivity between the assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197986      PMCID: PMC1976673          DOI: 10.1038/bjc.1984.9

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Direct cloning of human ovarian carcinoma cells in agar.

Authors:  A W Hamburger; S E Salmon; M B Kim; J M Trent; B J Soehnlen; D S Alberts; H J Schmidt
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

2.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

3.  Tissue-culture microtest for predicting response of human cancer to chemotherapy.

Authors:  H L Holmes; J M Little
Journal:  Lancet       Date:  1974-10-26       Impact factor: 79.321

4.  Testing anti-cancer drugs.

Authors:  J S Mitchell; P P Dendy; M P Dawson; T K Wheeler
Journal:  Lancet       Date:  1972-04-29       Impact factor: 79.321

5.  Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.

Authors:  T K Wheeler; P P Dendy; A Dawson
Journal:  Oncology       Date:  1974       Impact factor: 2.935

6.  Development of a clonogenic cell assay for human brain tumors.

Authors:  M L Rosenblum; D A Vasquez; T Hoshino; C B Wilson
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

7.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

8.  Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment.

Authors:  R I Freshney; J Paul; I M Kane
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

9.  Cell aggregates in the soft agar "human tumour stem-cell assay".

Authors:  M V Agrez; J S Kovach; M M Lieber
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

10.  Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.

Authors:  R J Berry; A H Laing; J Wells
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

View more
  10 in total

1.  Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.

Authors:  S P Cole
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Rapid assay for the in vitro chemosensitivity testing of human breast tumours. Control of assay conditions and quality assurance.

Authors:  R F Oude Elferink; H M Goldschmidt; H J Majoor; J F Leijten
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

3.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.

Authors:  F R Ahmann; H S Garewal; R Schifman; A Celniker; S Rodney
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

4.  Selective protection of tubercidin toxicity by nitrobenzyl thioinosine in normal tissues but not in human neuroblastoma cells.

Authors:  C Kaplinsky; H Yeger; Z Estrov; J Barankiewicz; G Pawlin; M H Freedman; A Cohen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.

Authors:  R A Vescio; C H Redfern; T J Nelson; S Ugoretz; P H Stern; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.

Authors:  Matthew J Schiewer; Robert Den; David T Hoang; Michael A Augello; Yaacov R Lawrence; Adam P Dicker; Karen E Knudsen
Journal:  Endocr Relat Cancer       Date:  2012-01-09       Impact factor: 5.678

7.  Comparison of assays used for in vitro chemosensitivity testing of human tumours.

Authors:  S E Salmon; F L Meyskens; D S Alberts
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

8.  Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.

Authors:  K H Wong; C J Koch; C A Wallen; K T Wheeler
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

9.  The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.

Authors:  P R Twentyman; G A Walls; K A Wright
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

10.  cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.

Authors:  A P Wilson; C H Ford; C E Newman; A Howell
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.